Frazier Healthcare Partners’ SPAC has found a partner. The venture firm inked a deal to bring Dutch biotech company NewAmsterdam Pharma public through a merger with its blank check company… Read More
Frazier Life Sciences announced the closure of a $987 million fund focused on biopharmaceuticals. The life sciences arm of the venture capital firm Frazier Healthcare Partners exceeded its $800 million… Read More
Alpine Immune Sciences will move a potential treatment for immune conditions into human testing and support its ongoing trials for cancer thanks to around $91 million in new funding. The… Read More